ArticleBMC cancer2024

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.

Monica Niger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.